[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368001-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-368001-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","comparative-pathophysiology-and-molecular-insights-into-cutaneous-and-non-cutaneous-canine-skin-cancers-focus-on-melanoma-mast-cell-tumors-and-squamous-cell-carcinoma","Comparative pathophysiology and molecular insights into cutaneous and non-cutaneous canine skin cancers - focus on melanoma, mast cell tumors, and squamous cell carcinoma","","Review synthesizing current literature on canine skin cancers, emphasizing mast cell tumors, melanoma, and squamous cell carcinoma. Discusses key pathophysiological drivers: KIT proto-oncogene mutations in mast cell tumors; BRAF and NRAS alterations shaping melanoma growth; and TP53 mutations and COX-2 upregulation linked to ultraviolet-driven carcinogenesis in SCC. Summarizes diagnostic approaches using cytology, histopathology, and immunohistochemical markers, and highlights staging tools including CT and PET. Reviews treatment options from surgery, radiation, and chemotherapy to targeted tyrosine kinase inhibitors and immunotherapies, aiming to improve early detection and prognosis through comparative oncology and translational medicine.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comparative-pathophysiology-and-molecular-insights-into-cutaneous-and-non-cutaneous-canine-skin-cancers-focus-on-melanoma-mast-cell-tumors-and-squamous-cell-carcinoma/368001/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comparative-pathophysiology-and-molecular-insights-into-cutaneous-and-non-cutaneous-canine-skin-cancers-focus-on-melanoma-mast-cell-tumors-and-squamous-cell-carcinoma/368001.png","ImageObject",300,407,{"name":42,"@type":43},"RuangKosong","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"Which canine skin cancer types are highlighted in this review?","Question",{"text":63,"@type":64},"The review focuses on mast cell tumors, melanoma, and squamous cell carcinoma, describing their clinical relevance and biological behavior.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What molecular mechanisms are linked to mast cell tumors, melanoma, and SCC?",{"text":68,"@type":64},"Mast cell tumors are often driven by KIT proto-oncogene mutations; melanoma involves BRAF and NRAS mutations; SCC is associated with chronic ultraviolet exposure, TP53 mutations, and increased COX-2 expression.",{"name":70,"@type":61,"acceptedAnswer":71},"How are these tumors diagnosed and staged?",{"text":72,"@type":64},"Diagnosis relies on cytology, histopathology, and immunohistochemical markers, while advanced imaging such as CT and PET can support staging and prognostication.",{"name":74,"@type":61,"acceptedAnswer":75},"What treatment strategies does the review discuss?",{"text":76,"@type":64},"Treatment varies by tumor type and stage and may include surgery, radiation, chemotherapy, and emerging targeted therapies. It also covers tyrosine kinase inhibitors for mast cell tumors and immunotherapies such as vaccines and checkpoint inhibitors.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},368001,1790218893,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":112,"preview_page_count":33,"preview_urls":149},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Review  \nPUBLISHED 27 November 2025 DOI 10.3389/fimmu.2025.1624598  \nOPEN ACCESS  \nEDITED BY  \nCarlos Eduardo Fonseca-Alves, Paulista University, Brazil  \nREVIEWED BY  \nEllen Sparger,  \nUniversity of California, Davis, United States Shima Saiyad,  \nGovernment of Gujarat, India  \n*CORRESPONDENCE  \nCamelia Munteanu  \n [camelia.munteanu@usamvcluj. ro](camelia.munteanu@usamvcluj. ro)  \nRECEIVED 07 May 2025  \nREVISED 29 October 2025  \nACCEPTED 12 November 2025  \nPUBLISHED 27 November 2025  \nCITATION  \nMˆarza SM, Munteanu C, Papuc I and Purdoiu RC (2025) Comparative pathophysiology and molecular insights into cutaneous and non-cutaneous canine skin cancers: focus on melanoma, mast cell tumors, and squamous cell carcinoma. Front. Immunol. 16:1624598 .  \ndoi: 10.3389/fimmu.2025.1624598  \nCOPYRIGHT  \n© 2025 Mˆarza, Munteanu, Papuc and Purdoiu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nComparative pathophysiology and molecular insights into cutaneous and non-cutaneous canine skin cancers: focus on melanoma, mast cell tumors, and squamous cell carcinoma  \nSorin Marian Mˆarza 1, Camelia Munteanu 2*, Ionel Papuc 1 and Robert Cristian Purdoiu 1  \n1 Faculty of Veterinary Medicine, University of Agricultural Science and Veterinary Medicine,  \nCluj-Napoca, Romania, 2 Biology Section, Faculty of Agriculture, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania  \nSkin cancer is one of the most frequently diagnosed neoplasms in dogs, encompassing a range of malignancies with signiﬁcant clinical implications. Among them, mast cell tumors (MCTs), melanomas, and squamous cell carcinomas (SCCs) signify the most common and clinically relevant types, each posing distinct therapeutic challenges and exhibiting pathophysiological mechanisms. MCTs, accounting for approximately 21% of canine skin tumors, are often driven by mutations in the KIT proto-oncogene, leading to an uncontrolled proliferation of mast cells. Melanomas, while typically benign in cutaneous forms, exhibit aggressive behavior in oral and digital locations, with BRAF and NRAS mutations playing an integral role in tumor growth. Furthermore, SCCs, primarily associated with chronic ultraviolet (UV) radiation exposure, demonstrate signiﬁcant genomic modiﬁcations, including mutations in TP53 and increased expression of COX-2, resulting in carcinogenesis. Accurate diagnosis of these tumors signiﬁcantly relies on cytology, histopathology, and immunohistochemical markers. Moreover, advanced imaging techniques such as computed tomography (CT) and positron emission tomography (PET) can potentially enhance staging and prognostication. Treatment modalities vary based on tumor type and stage, including surgical excision, radiation therapy, chemotherapy, and emerging targeted therapies. Tyrosine kinase inhibitors (TKIs), such as toceranib phosphate (Palladia) and masitinib, have demonstratedefﬁcacy in MCTs. Likewise, immunotherapies, including the Oncept melanoma vaccine and checkpoint inhibitors, offer novel therapeutic avenues. Comparative oncology continues to underscore molecular similarities between canine and human skin cancers, advancing translational research and developing precision medicine techniques in veterinary oncology. This review comprehensively synthesizes state-of-the-art literature on canine skin cancer, addressing  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \npathophysiological mechanisms, diagnostic advancements, and emerging therapeutic strategies. In addition, this review aims to improve early detection, treatment outcomes,","cbCaibGCkzKHHZId","https://ap.wps.com/l/cbCaibGCkzKHHZId","pdf",1500758,16,"English","# Introduction\n## Canine skin cancer overview\n## Mast cell tumors and molecular drivers\n## Melanoma and comparative oncology\n## Squamous cell carcinoma and ultraviolet-associated mechanisms\n## Diagnosis, imaging, and prognosis\n## Treatment options and emerging therapies","[{\"question\":\"Which canine skin cancer types are highlighted in this review?\",\"answer\":\"The review focuses on mast cell tumors, melanoma, and squamous cell carcinoma, describing their clinical relevance and biological behavior.\"},{\"question\":\"What molecular mechanisms are linked to mast cell tumors, melanoma, and SCC?\",\"answer\":\"Mast cell tumors are often driven by KIT proto-oncogene mutations; melanoma involves BRAF and NRAS mutations; SCC is associated with chronic ultraviolet exposure, TP53 mutations, and increased COX-2 expression.\"},{\"question\":\"How are these tumors diagnosed and staged?\",\"answer\":\"Diagnosis relies on cytology, histopathology, and immunohistochemical markers, while advanced imaging such as CT and PET can support staging and prognostication.\"},{\"question\":\"What treatment strategies does the review discuss?\",\"answer\":\"Treatment varies by tumor type and stage and may include surgery, radiation, chemotherapy, and emerging targeted therapies. It also covers tyrosine kinase inhibitors for mast cell tumors and immunotherapies such as vaccines and checkpoint inhibitors.\"}]","Comparative pathophysiology and molecular insights into cutaneous and non-cutaneous canine skin cancers - focus on melanoma, mast cell tumors, and squamous cell carcinoma | PDF",1790174289,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59bd79010d5ac6fd14dcd9feace6cf6a.webp",983,1389,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b531473bf50470e25b10f3f83d66b41e.webp",982,1388,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aef9ab6523c08f7a5f96d3d8371f8204.webp",981,1387,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bd7aa854678d58db78e3b8e73a3fcbd.webp",980,1385]